Role of Natural Bioactive Compounds in the Rise and Fall of Cancers : Volume 2
Recent years have seen the idea of a close association between nutrition and the modulation of cancer development/progression reinforced. An increasing amount of experimental and epidemiological evidence has been produced supporting the concept that many different bioactive components of food (e.g....
Saved in:
| Sonstige: | |
|---|---|
| Year of Publication: | 2020 |
| Language: | English |
| Physical Description: | 1 electronic resource (318 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993545456304498 |
|---|---|
| ctrlnum |
(CKB)5400000000043034 (oapen)https://directory.doabooks.org/handle/20.500.12854/69198 (EXLCZ)995400000000043034 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Luparello, Claudio edt Role of Natural Bioactive Compounds in the Rise and Fall of Cancers Volume 2 Role of Natural Bioactive Compounds in the Rise and Fall of Cancers Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020 1 electronic resource (318 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Recent years have seen the idea of a close association between nutrition and the modulation of cancer development/progression reinforced. An increasing amount of experimental and epidemiological evidence has been produced supporting the concept that many different bioactive components of food (e.g. polyphenols, mono- and polyunsaturated fatty acids, methyl-group donors, etc.) may be implicated in either the promotion of or the protection against carcinogenesis. At the cellular level, such compounds can have an impact on different but sometimes intertwined processes, such as growth and differentiation, DNA repair, programmed cell death, and oxidative stress. In addition, compelling evidence is starting to build up of the existence of primary epigenetic targets of dietary compounds, such as oncogenic/oncosuppressor miRNAs or DNA-modifying enzymes, which in turn impair gene expression and function. Since there is a growing interest in the study of the biochemical and molecular role played by food components and its impact on cellular processes and/or gene expressions directed towards the fine-tuning of cancer phenotypes, in this Special Issue researchers contributed with either research or review articles presenting the latest findings on the intracellular pathways and mechanisms affected by natural bioactive dietary molecules. English Research & information: general bicssc Biology, life sciences bicssc berberine signaling pathways oncogenic cascades TRAIL microRNAs cancer therapy colon cancer cells ethanol Nrf2 HO-1 ER stress autophagy MMPs formononetin cancer preclinical models cell signaling angiogenesis nobiletin colorectal cancer chemoprevention bioactivities experimental therapeutics HDAC multiple myeloma oleacein breast cancer persistent organic pollutants breast cancer risk breast cancer prognostic systematic review carrageenan invasion metastasis RacGAP1 radiotherapy marine sponge natural product anticancer drug oral cancer inhibition phytochemicals small organic agents Piper eriopodon, alkenylphenols human cancer cells cell death apoptosis caspase-independent cell death XIAP antagonists XIAP-BIR3 domain Calocedrus formosana lung cancer yatein cell-cycle arrest xenograft isorhamnetin G2/M arrest ROS AMPK pancreatic cancer epigallocatechin-3-gallate (EGCG) gemcitabine glycolysis phosphofructokinase natural polyphenols anticancer activities molecular mechanisms Streptomyces mangrove anti-proliferative colon cancer epithelial mesenchymal transition inflammation malignant cancer natural anti-inflammatory compounds pro-resolving lipids anticancer drugs flavonoids natural compounds Xenopus laevis AOM/DSS model melanoma cells nicotine α9-nAChR PD-L1 STAT3 gigantol AKT JAK/STAT cancer stem cell tumor maintenance tumor density proteomics honokiol anticancer mechanism signalling pathway uterine sarcoma fucoidan isobolography colchicine alkaloid mesoporous silica nanoparticles targeted delivery system PD-1 immune checkpoint inhibitor and cancer immunotherapy glucose transport drugs innate immunity β-glucans nutrition immunotherapy estrogen estrogen receptor alpha polyphenols daidzein daidzein metabolites paclitaxel breast cancer cells obesity renin-angiotensin system eicosapentaenoic acid adipocyte inflammation olive leaf extract oleuropein Seahorse analysis cancer metabolism glycolytic markers Malva pseudolavatera Webb & Berthel. acute myeloid leukemia reactive oxygen species brain cancer gliomas schwannomas malignant tumors of the peripheral nerve sheath (MPNST) neurofibromas bioavailability nanoparticle-based delivery systems natural bioactive compound gallic acid EGFR signaling p53 EGCG non-coding RNAs anti-cancer drug NSCLC EGFR TKI FASN inhibitors resistance 3-03943-292-3 3-03943-293-1 Luparello, Claudio oth |
| language |
English |
| format |
eBook |
| author2 |
Luparello, Claudio |
| author_facet |
Luparello, Claudio |
| author2_variant |
c l cl |
| author2_role |
Sonstige |
| title |
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers Volume 2 |
| spellingShingle |
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers Volume 2 |
| title_sub |
Volume 2 |
| title_full |
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers Volume 2 |
| title_fullStr |
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers Volume 2 |
| title_full_unstemmed |
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers Volume 2 |
| title_auth |
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers Volume 2 |
| title_alt |
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers |
| title_new |
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers |
| title_sort |
role of natural bioactive compounds in the rise and fall of cancers volume 2 |
| publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
| publishDate |
2020 |
| physical |
1 electronic resource (318 p.) |
| isbn |
3-03943-292-3 3-03943-293-1 |
| illustrated |
Not Illustrated |
| work_keys_str_mv |
AT luparelloclaudio roleofnaturalbioactivecompoundsintheriseandfallofcancersvolume2 AT luparelloclaudio roleofnaturalbioactivecompoundsintheriseandfallofcancers |
| status_str |
n |
| ids_txt_mv |
(CKB)5400000000043034 (oapen)https://directory.doabooks.org/handle/20.500.12854/69198 (EXLCZ)995400000000043034 |
| carrierType_str_mv |
cr |
| is_hierarchy_title |
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers Volume 2 |
| author2_original_writing_str_mv |
noLinkedField |
| _version_ |
1796649061566119936 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>07105nam-a2202077z--4500</leader><controlfield tag="001">993545456304498</controlfield><controlfield tag="005">20231214133155.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000043034</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/69198</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000043034</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Luparello, Claudio</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Role of Natural Bioactive Compounds in the Rise and Fall of Cancers</subfield><subfield code="b">Volume 2</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Role of Natural Bioactive Compounds in the Rise and Fall of Cancers </subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (318 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Recent years have seen the idea of a close association between nutrition and the modulation of cancer development/progression reinforced. An increasing amount of experimental and epidemiological evidence has been produced supporting the concept that many different bioactive components of food (e.g. polyphenols, mono- and polyunsaturated fatty acids, methyl-group donors, etc.) may be implicated in either the promotion of or the protection against carcinogenesis. At the cellular level, such compounds can have an impact on different but sometimes intertwined processes, such as growth and differentiation, DNA repair, programmed cell death, and oxidative stress. In addition, compelling evidence is starting to build up of the existence of primary epigenetic targets of dietary compounds, such as oncogenic/oncosuppressor miRNAs or DNA-modifying enzymes, which in turn impair gene expression and function. Since there is a growing interest in the study of the biochemical and molecular role played by food components and its impact on cellular processes and/or gene expressions directed towards the fine-tuning of cancer phenotypes, in this Special Issue researchers contributed with either research or review articles presenting the latest findings on the intracellular pathways and mechanisms affected by natural bioactive dietary molecules.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Research & information: general</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biology, life sciences</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">berberine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">signaling pathways</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oncogenic cascades</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TRAIL</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microRNAs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">colon cancer cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ethanol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Nrf2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HO-1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ER stress</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">autophagy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MMPs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">formononetin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">preclinical models</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cell signaling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">angiogenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nobiletin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">colorectal cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chemoprevention</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bioactivities</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">experimental therapeutics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HDAC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multiple myeloma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oleacein</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">persistent organic pollutants</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">breast cancer risk</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">breast cancer prognostic</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">systematic review</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">carrageenan</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">invasion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metastasis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">RacGAP1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">marine sponge</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">natural product</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anticancer drug</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oral cancer inhibition</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phytochemicals</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">small organic agents</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Piper eriopodon, alkenylphenols</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">human cancer cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cell death</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">apoptosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">caspase-independent cell death</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">XIAP antagonists</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">XIAP-BIR3 domain</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Calocedrus formosana</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lung cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">yatein</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cell-cycle arrest</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">xenograft</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">isorhamnetin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">G2/M arrest</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ROS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">AMPK</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pancreatic cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epigallocatechin-3-gallate (EGCG)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gemcitabine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glycolysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phosphofructokinase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">natural polyphenols</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anticancer activities</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular mechanisms</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Streptomyces</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mangrove</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anti-proliferative</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">colon cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epithelial mesenchymal transition</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inflammation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">malignant cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">natural anti-inflammatory compounds</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pro-resolving lipids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anticancer drugs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">flavonoids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">natural compounds</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Xenopus laevis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">AOM/DSS model</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">melanoma cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nicotine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">α9-nAChR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PD-L1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">STAT3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gigantol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">AKT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">JAK/STAT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer stem cell</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor maintenance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor density</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">proteomics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">honokiol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anticancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mechanism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">signalling pathway</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">uterine sarcoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fucoidan</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">isobolography</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">colchicine alkaloid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mesoporous silica nanoparticles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">targeted delivery system</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PD-1 immune checkpoint inhibitor and cancer immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glucose transport</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drugs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">innate immunity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">β-glucans</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nutrition</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">estrogen</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">estrogen receptor alpha</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polyphenols</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">daidzein</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">daidzein metabolites</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">paclitaxel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">breast cancer cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">obesity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">renin-angiotensin system</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">eicosapentaenoic acid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adipocyte inflammation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">olive leaf extract</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oleuropein</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Seahorse analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer metabolism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glycolytic markers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Malva pseudolavatera Webb &amp</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Berthel.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">acute myeloid leukemia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">reactive oxygen species</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">brain cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gliomas</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">schwannomas</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">malignant tumors of the peripheral nerve sheath (MPNST)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neurofibromas</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bioavailability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanoparticle-based delivery systems</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">natural bioactive compound</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gallic acid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">EGFR signaling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">p53</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">EGCG</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-coding RNAs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anti-cancer drug</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NSCLC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">EGFR TKI</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FASN inhibitors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">resistance</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-292-3</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-293-1</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Luparello, Claudio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:45:34 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337939450004498&Force_direct=true</subfield><subfield code="Z">5337939450004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337939450004498</subfield></datafield></record></collection> |